Proto Labs (PRLB) Cash & Equivalents (2011 - 2026)

Proto Labs' Cash & Equivalents history runs 16 years deep, the most recent figure standing at $124.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 49.92% year-over-year to $124.0 million; the TTM figure through Mar 2026 stood at $124.0 million (up 49.92% YoY), while the FY2025 annual figure was $110.8 million, up 24.42% from the prior year.
• Cash & Equivalents came in at $124.0 million for Q1 2026 at Proto Labs, up from $110.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $124.0 million in Q1 2026 to a low of $54.7 million in Q2 2022.
• A 5-year average of $82.5 million and a median of $83.8 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents declined 14.21% in 2022 and jumped 49.92% in 2026, its largest moves.
• Proto Labs' Cash & Equivalents stood at $56.6 million in 2022, then surged by 48.15% to $83.8 million in 2023, then increased by 6.3% to $89.1 million in 2024, then advanced by 24.42% to $110.8 million in 2025, then grew by 11.86% to $124.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $124.0 million, $110.8 million, and $104.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison